New UK pharma code limits gifts but frees pharmacists
Posted 14th July 2010 in Articles, Commercial | 2 comments
The UK’s pharma authority has proposed a new code of practice and Steve Gray ponders what impact it might have on pharmaceutical industry promotion.
So, it’s now official – there will be a new code in 2011 and it goes live on 1st January. The proposals have been…
Read the full articleThe market access myth
Posted 12th July 2010 in Articles, Commercial | Register to comment
In the second of his two perspective pieces on pharma marketing, Chris Rose proposes that market access is a state of mind, not a role in itself.
The idea that market access is a single role within the pharma business has evolved over recent years as the power of the “payor” has increased. This is a…
Read the full articleSlow, safe steps into the sticky new world
Posted 9th July 2010 in Articles, Commercial | 1 comment
As the world of social media seems to move at an incredible pace, Emma D’Arcy looks at what has changed in pharma’s approach to it in the last year.
In July 2009 I published the results of a series of interviews with pharmaceutical companies…
Read the full articleThe top model in pharma
Posted 5th July 2010 in Articles, Commercial | 3 comments
In the first of two articles, Chris Rose speculates that amidst a flurry of radical new business models perhaps pharma just needs to look outside for some simple answers.
As Tyra selects the latest size 6 model to take the American fashion scene by storm, pharma executives are struggling to identify…
Read the full articleMarket Access in Europe: The view ahead
Posted 25th June 2010 in Articles, Commercial, Interviews | Register to comment
Following Cegedim Dendrite’s recent research into European market access for drugs, pharmaphorum interviewed UK General Manager David Round to hear his perspective first-hand.
As a key partner supporting the pharma industry’s initiatives to engage with an increasingly diverse customer base, Cegedim Dendrite recently conducted…
Read the full articleThe opportunity for India in the global biosimilars market
Posted 21st June 2010 in Articles, Commercial | 2 comments
As big pharma eyes the growing market for biosimilars in the West, Syamala Ariyanchira asks whether the traditional Indian generics giants can compete in this space.
Dr. Reddy’s Laboratories (DRL) of India launched its first biosimilar product, Grafeel (filgrastim), in 2001 in India…
Read the full articleAn insight into generic patent strategies
Posted 14th June 2010 in Articles, Commercial, Interviews | Register to comment
In the first of a series of interviews we will be featuring on pharmaphorum, Paul Tunnah spoke with Pam Politis to talk about generic patent strategies.
pharmaphorum caught up with Pam Politis, Senior Patent Attorney for Endo Pharmaceuticals in the US…
Read the full articleWhat is key account management (Part 2)?
Posted 2nd June 2010 in Articles, Commercial | 5 comments
In the second and final part of this two part series, Hanno Wolfram elaborates on the role of the Key Account Manager and what skills are required for them to be successful.
In part 1 of this article, we explored the varying definitions of key accounts in the context of key account management…
Read the full articleWhat is key account management (Part 1)?
Posted 27th May 2010 in Articles, Commercial | 1 comment
In the first part of a two part article, Hanno Wolfram explores the term ‘key account management’ and asks whether we really understand what it means.
Once you search in Google for “key account management” the number of hits is about 197 million…
Read the full articleWake up advertising…things have changed!
Posted 24th May 2010 in Articles, Commercial | 2 comments
As digital media permeates the very fabric of how we promote brands, experienced advertising executive Ángel González embraces the exciting change it brings.
A few months before, I decided to make a radical change to my life by learning to become an entrepreneur…
Read the full article